Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Nov 28, 2020 3:06pm
137 Views
Post# 31995150

RE:RE:RE:Time To Add.

RE:RE:RE:Time To Add.Stinzo, I sense some frustration, some warranted.

They never said they can't travel to Germany,

"Acquired pieces of equipment suitable for the assembling of a commercial scale PGX unit. Timelines to initiate building of the customized large scale unit to be defined due to COVID-19 travel restrictions and resulting availability of expert personnel."

I don't know who the expert personnel are but they could be from hot spots and not solely CZO employees.

What would be the purpose of buying back shares: just to temporarily prop up the share price?  This is a growth stock, a company transitioning to biopharma.  They are setting up equipment (2 locations) and a new plant for commercial production.  In addition they have mentioned that since they have so many products in the pipeline, they would prioritize how they will allocate capital.  Perhaps this is why we hear about potential applications for insulin, then nothing thereafter. After the last raise in 2016, we should be grateful, yes grateful that we have not seen dilution in our shares from the need to raise capital.

Stinzo wrote: I

One thing I would like to point out tho, is the false claim that they can't travel to Germany to work on the plant. I have taken few planes in the last 6 months between Canada and Europe with no difficulty and on a personal basis. So a bit hard for me to swallow that their german execution is delayed because of travel. There is planes flying and all countries accept work reasons, even easier if they can use their life science background. 

Base business is doing great, but unless they use some of that 6 M on buying back shares, the profit from the base business is not giving me any extra value. 



<< Previous
Bullboard Posts
Next >>